Archford Capital Strategies’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
IF
HCM
MSRI
PWM
ATC
QFA
SWM
WPW
CCWA
Archford Capital Strategies's IBDX Position: Q2 2026 in Review
Archford Capital Strategies reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 5.3% in Q2 2026, selling an estimated $114K and leaving 80,541 shares worth $2.03M. The position accounts for 0.21% of the portfolio, ranked #100.
Archford Capital Strategies first reported a position in IBDX in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.21M in Q4 2025. 34 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.
- Archford Capital Strategies held 80,541 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.03M as of Q2 2026.
- Archford Capital Strategies sold 4,522 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $114K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.21% of Archford Capital Strategies's portfolio in Q2 2026, its #100 holding.
- Archford Capital Strategies first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
- Archford Capital Strategies's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $2.21M in Q4 2025.
- 34 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.
Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.